Navigation Links
Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care

Shared Physicians, Diagnosis, Locations, and Research Benefit Regional Cancer Patients

NEW ORLEANS, April 28 /PRNewswire/ -- Ochsner Health System ( and LSU Health Sciences Center, New Orleans ( have announced a partnership to better serve the region's cancer patients by combining clinical care and cancer research in order to advance patient treatment options and provide better access to care. This collaboration will also further the development of critical, translational research, bridging the gap between research and the delivery of new therapies by allowing research to move rapidly from the laboratory into additional early phase clinical trials and new treatments for cancer patients.

The partnership between the two medical leaders began in 2008 and is centered on combining LSUHSC, the state's largest cancer research facility, with Ochsner, the state's largest clinical cancer provider, to bring better local access to comprehensive cancer care. Patients will benefit from this partnership by having access to the latest research trials and treatments closer to home and the ability to receive comprehensive cancer care through a combined network of local physicians and neighborhood locations. LSUHSC and Ochsner patients will have access to cancer services at both organizations.

"Southeast Louisiana residents will now have a truly diverse 'team' of cancer care experts, clinical experts and research leaders, dedicated to providing compassionate and comprehensive cancer care within the local community," said Dr. John Cole, M.D., Head of Hematology/Oncology at Ochsner Medical Center and Acting Chief of Hematology/Oncology at LSU Health Sciences Center New Orleans. "By combining our expertise, patients will no longer have to travel outside Louisiana to get the most current cancer treatments or participate in potentially lifesaving clinical trials."

"The joint program will allow scientists and clinicians to jointly study the most frequent cancers in our region and design new ways to prevent, diagnose and treat them," notes Dr. Augusto Ochoa, Director of the LSUHSC Stanley S. Scott Cancer Center.

"This partnership was developed from mutual commitment to provide the best care for our communities. Ochsner and LSUHSC have a long tradition of partnership through shared medical education and research trials; however, this latest collaboration will have a more direct impact on residents lives," explains Warner Thomas, President and Chief Operating Officer of Ochsner Health System.

"LSU Health Sciences Center and Ochsner have a number of joint training programs for resident physicians," said Dr. Larry Hollier, Chancellor of LSU Health Sciences Center New Orleans. "This new initiative in clinical cancer care will expand the ability of both institutions to provide the latest diagnosis and treatment for a broad range of cancer patients. This is an important milestone in the recovery of health care services for people in the New Orleans area."

SOURCE Ochsner Health System
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
6. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
7. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
9. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
10. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
11. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... November 24, 2015 --> ... research report "Oligonucleotide Synthesis Market by Product & Services ... Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, ... MarketsandMarkets, the market is expected to reach USD 1,918.6 ... at a CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... 2015 SHPG ) announced today that ... Jaffray 27 th Annual Healthcare Conference in New ... 8:30 a.m. EST (1:30 p.m. GMT). --> SHPG ) ... participate in the Piper Jaffray 27 th Annual Healthcare Conference ... December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... Fingerprint Sensors - Technology and Patent Infringement Risk Analysis" ... --> --> Fingerprint sensors using capacitive ... The fingerprint sensor vendor Idex forecasts an increase of ... mobile devices and of the fingerprint sensor market between ...
(Date:11/20/2015)... 2015 NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... was recently interviewed on The RedChip Money Report ... weekend on Bloomberg Europe , Bloomberg Asia, Bloomberg ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:11/19/2015)... , Nov. 19, 2015  Based on its in-depth ... Sullivan recognizes BIO-key with the 2015 Global Frost & ... Frost & Sullivan presents this award to the company ... to the needs of the market it serves. The ... meets and expands on customer base demands, the overall ...
Breaking Biology News(10 mins):